Lv1
50 积分 2024-09-21 加入
TME/NIR Dual‐Responsive Zinc‐Based Targeted Nanoagonist for Multimodal Amplification of STING‐Mediated Cancer Immunotherapy
2个月前
已完结
Engineering biodegradable lipid nanoparticles with endo-lysosomal escape capability for chronological therapeutic immunomodulation to enhance interleukin-15 therapy
3个月前
已完结
Amino acid supplementation enhances in vivo efficacy of lipid nanoparticle–mediated mRNA delivery in preclinical models
4个月前
已完结
Macrophages: Targets for next-generation cancer immunotherapy
6个月前
已完结
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial
6个月前
已完结
皖公网安备34019202002308
